CARA THERAPEUTICS INC (CARA)

US1407551092 - Common Stock

0.7  +0.03 (+4.23%)

After market: 0.706 +0.01 (+0.86%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CARA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.33. This target is 661.88% above the current price.
CARA was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CARA.
In the previous month the buy percentage consensus was at a similar level.
CARA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.701.015.105.3310.50 - 44.29% 628.57% 661.88% 1,400.00%
Up and Down Grades
Date Firm Action Rating
2024-04-10 Needham Reiterate Buy -> Buy
2024-03-28 Needham Reiterate Buy -> Buy
2024-03-06 Canaccord Genuity Maintains Buy -> Buy
2024-03-05 Needham Reiterate Buy -> Buy
2024-01-22 Needham Maintains Buy -> Buy
2023-12-19 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-18 Needham Maintains Buy -> Buy
2023-11-14 Piper Sandler Downgrade Overweight -> Neutral
2023-10-19 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-08 Needham Reiterate Buy -> Buy
2023-08-08 Piper Sandler Maintains Overweight -> Overweight
2023-06-27 Stifel Reiterate Buy -> Buy
2023-06-27 Jefferies Reiterate Buy -> Buy
2023-05-16 Needham Reiterate Buy
2023-05-16 B of A Securities Maintains Underperform -> Underperform
2023-05-16 HC Wainwright & Co. Maintains Buy -> Buy
2023-04-18 Needham Reiterate Action List Buy
2023-04-04 Needham Reiterate Buy
2023-03-08 B of A Securities Downgrade Neutral -> Underperform
2023-03-07 Needham Maintains Buy
2023-03-07 JP Morgan Maintains Overweight
2023-03-07 Canaccord Genuity Maintains Buy
2023-03-07 Piper Sandler Maintains Overweight
2023-03-07 HC Wainwright & Co. Maintains Buy
2023-02-17 Needham Reiterate Buy
2023-02-14 HC Wainwright & Co. Maintains Buy
2022-03-08 JP Morgan Upgrade Neutral -> Overweight
2021-08-24 HC Wainwright & Co. Maintains Buy
2021-08-03 JP Morgan Initiate Neutral
2021-04-29 Needham Maintains Buy